Rxivist logo

Human stem cell model of HNF1A deficiency shows uncoupled insulin to C-peptide secretion with accumulation of abnormal insulin granules

By Bryan J Gonzalez, Haoquan Zhao, Jacqueline Niu, Damian J. Williams, Jaeyop Lee, Christopher N Goulbourne, Yuan Xing, Yong Wang, Jose Oberholzer, Xiaojuan Chen, Charles A LeDuc, Wendy K. Chung, Henry M. Colecraft, Jesper Gromada, Yufeng Shen, Robin S. Goland, Rudolph L Leibel, Dieter Egli

Posted 26 Jan 2021
bioRxiv DOI: 10.1101/2021.01.26.428260

Mutations in HNF1A cause Maturity Onset Diabetes of the Young type 3 (MODY3), the most prevalent form of monogenic diabetes. We generated stem cell-derived pancreatic endocrine cells from human embryonic stem cells (hESCs) with induced hypomorphic mutations in HNF1A. Using these cells, we show that HNF1A orchestrates a transcriptional program required for distinct aspects of beta cell fate and function. During islet cell differentiation, HNF1A deficiency biases islet endocrine cells towards an alpha cell fate associated with PAX4 down-regulation. HNF1A-deficient beta cells display impaired basal and glucose stimulated-insulin secretion in association with a reduction in CACNA1A and intracellular calcium levels, and impaired insulin granule exocytosis in association with SYT13 down-regulation. Knockout of PAX4, CACNA1A and SYT13 reproduce the relevant phenotypes. Reduction of insulin secretion is associated with accumulation of enlarged secretory granules, and altered stoichiometry of secreted insulin to C-peptide. In HNF1A deficient beta cells, glibenclamide, a sulfonylurea drug used in the treatment of MODY3 patients, increases intracellular calcium to levels beyond those achieved by glucose, and restores C-peptide and insulin secretion to a normal stoichiometric ratio. To study HNF1A deficiency in the context of a human disease model, we also generated stem cell-derived pancreatic endocrine cells from two MODY3 patient's induced pluripotent stem cells (iPSCs). While insulin secretion defects are constitutive in cells with complete HNF1A loss of function, beta cells heterozygous for hypomorphic HNF1A mutations are initially normal, but lose the ability to secrete insulin and acquire abnormal stoichiometric secretion ratios. Importantly, the defects observed in these stem cell models are also seen in circulating proportions of insulin:C-peptide in nine MODY3 patients.

Download data

  • Downloaded 724 times
  • Download rankings, all-time:
    • Site-wide: 41,696
    • In cell biology: 1,679
  • Year to date:
    • Site-wide: 6,941
  • Since beginning of last month:
    • Site-wide: 13,090

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide